Erik Stilp

An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization.

Landmark trials comparing carotid endarterectomy (CEA) with medical therapy in patients with symptomatic or asymptomatic atherosclerotic stenosis of extracranial carotid arteries have favored carotid revascularization. Carotid artery stenting (CAS) has emerged as a minimally invasive option for revascularization of carotid artery stenoses and has been shown to be noninferior to CEA, regardless of patient symptom status. Debate continues regarding the importance of periprocedural myocardial infarction (PMI) as an endpoint in carotid revascularization trials. Recent randomized comparisons of CEA and CAS pre‐specify PMI as an endpoint. Understanding PMI in CEA and CAS, the need for routine biomarker assessment surrounding both revascularization strategies, the effect of PMI on long‐term morbidity and mortality, and the groups most at risk for PMI are of critical importance when choosing a carotid revascularization strategy for symptomatic and asymptomatic patients, since decreasing the incidence of PMI will make revascularization safer. This review examines available data regarding the relevance of PMI in vascular and carotid‐specific outcomes.

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent

The endovascular management of obstructive disease of the superficial femoral artery (SFA) is challenging due to unique anatomical and biomechanical forces. Obstructive lesions of the SFA make up the largest proportion of lesions leading to symptomatic peripheral arterial disease. Accordingly, endovascular treatment of SFA disease is becoming increasingly common and, in many cases, is the preferred initial therapy. The use of self-expanding nitinol stents have proven superior to percutaneous transluminal balloon angioplasty in the treatment of intermediate length SFA stenosis. However, achieving durable results, as well as attaining adequate therapy for long occlusions typically seen in clinical practice, remains problematic. Newer technologies, such as paclitaxel eluting stents, seem promising in improving outcomes.

Carotid stenting versus endarterectomy for the treatment of carotid artery stenosis: Contemporary results from a large single center study.

To compare the complication rates associated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS).

Carotid Revascularization: A Systematic Review of the Evidence

OBJECTIVE AND BACKGROUND The aim of this study is to provide an evidence-based review of the periprocedural safety and long-term effectiveness of carotid artery stenting (CAS) compared to carotid endarterectomy (CEA), with particular attention paid to the use of embolic protection devices and patients at high risk for CEA. METHODS Electronic databases (Ovid Medline, Cochrane central register of controlled trials, Pubmed, and Embase) were searched to identify: (1) randomized controlled trials (RCT) comparing outcomes of CEA and CAS, and (2) prospective clinical trials assessing the safety of CAS in patients at high surgical risk. Pooled incidence rates and one-sided 95% confidence interval for the periprocedural and long-term composite end-point of stroke, myocardial infarction, or death among high surgical risk patients were generated and compared to objective performance criteria (OPC) reported by previous trials. RESULTS Six RCTs and 14 prospective clinical trials met our search criteria. Selected RCTs showed inconsistency in reported periprocedural and long-term outcome rates. Pooled incidence rates of the periprocedural and long-term composite end-point of stroke, myocardial infarction or death in high surgical risk candidates were 5.59% and 7.92%, respectively. These results were noninferior to selected OPCs (P-value <0.001). CONCLUSIONS CAS represents a safe and effective stroke prevention strategy in high surgical risk patients when compared with CEA. The inconsistent results from the RCTs and the improved outcomes in the prospective clinical trials are likely related to variability in operator experience, use of embolic protection devices, and patient selection strategies.

Dysautonomic responses during percutaneous carotid intervention: principles of physiology and management.

Percutaneous carotid artery stenting (CAS) has emerged as a less invasive alternative to carotid endarterectomy for the treatment of carotid atherosclerotic disease. The main risk of CAS is the occurrence of neuro‐vascular complications; however, carotid artery stenting‐related dysautonomia (CAS‐D) (hypertension, hypotension, and bradycardia) is the most frequently reported problem occurring in the periprocedural period. Alterations in autonomic homeostasis result from baroreceptor stimulation, which occurs particularly at the time of balloon inflation in the region of the carotid sinus. The response can be profound enough to induce asystole or even complete cessation of postganglionic sympathetic nerve activity. Frequency and factors predisposing a patient to CAS‐D have been investigated in several studies; however, there are significant discrepancies in results among reports. Lack of consistent findings may arise from using different methods and definitions, as well as other factors discussed in detail in this review. Furthermore, a correlation of CAS‐D with short and long‐term outcomes has been investigated only in small and mostly retrospective studies, explaining why its prognostic significance remains uncertain. In this manuscript, we have focused on risk factors, pathophysiology and management of periprocedural autonomic dysfunction. As there is no standardized approach to the treatment of CAS‐D, we present an algorithm for the periprocedural management of patients undergoing CAS. The proposed algorithm was developed based on our procedural experience as well as data from the available literature. The Yale Algorithm was successfully implemented at our institution and we are currently collecting data for short‐ and long‐term safety.

Carotid stent deformation: Sonographic findings and CT correlation

Carotid artery dissection is a rare but potentially serious complication of endovascular procedures in the carotid arteries. Stent deformation or incomplete expansion may occur following endovascular repair of an iatrogenic carotid artery dissection and may mimic stent fracture. We report an unusual case of deformation of a common carotid artery open cell design stent following endovascular repair of an iatrogenic dissection, which resulted in persistent blood flow between the stent and the wall of the common carotid artery. Sonographic features are described and correlation with intravascular ultrasound and CT is provided.

Hepatocellular Carcinoma Metastatic to the Right Ventricle

![Figure][1] [![Graphic][3] ][3][![Graphic][4] ][4] A 71-year-old man with a history of hepatocellular carcinoma presented with chest pain. An exercise myocardial perfusion scan showed anterior and inferior ischemia, and angiography demonstrated a long tubular stenosis of the mid

Recovery of left ventricular function after percutaneous revascularization of a left main chronic total occlusion

Surgical revascularization of left main and/or three‐vessel coronary artery disease (CAD) is associated with improved survival in patients with left ventricular dysfunction when compared to medical therapy and can result in improved left ventricular ejection fraction (LVEF) [ 1 ]. Multivessel percutaneous coronary intervention (PCI) is equivalent to surgery regarding short and intermediate term mortality, and left main PCI has emerged as a safe and effective alternate to surgical revascularization [ 2 ]. However, outcomes of unprotected left main PCI in patients with severely depressed LVEF have not been examined. We report a patient with left main chronic total occlusion, multivessel CAD, and dilated cardiomyopathy, in whom complete revascularization via PCI resulted in decreased left ventricular size and improved LVEF.

Computer-assisted detection of tardus parvus waveforms on Doppler ultrasound:

Objective To determine if a novel computer-generated metric, effective acceleration time, improves accuracy for detecting tardus parvus waveforms on spectral Doppler ultrasound. Methods Patients with echocardiography-confirmed aortic valve stenosis (n = 132; 60 mild, 44 moderate, 28 severe) and matched controls (n = 48) who underwent carotid Doppler ultrasound were identified through an imaging database search at a single medical center. A custom-built spectral analysis computer program generated effective acceleration time values for spectral Doppler waveforms in the carotid arteries and a receiver operating characteristic analysis was performed to determine the optimal median effective acceleration time cutoff value to detect tardus parvus waveforms. Two radiologists, blinded to subject disease status, reviewed and rated all carotid sonograms for presence of tardus parvus waveforms. Inter-rater variability was measured, and the accuracy of aortic valve stenosis detection with and without use of the effective acceleration time cutoff was calculated. Results Receiver operating characteristic analysis revealed an optimal effective acceleration time cutoff of ≥ 48 ms with a corresponding area under the curve of 0.77 (95% CI: 0.70–0.84). Use of the effAT cutoff demonstrated an accuracy of 74%. Accuracy of visual waveform interpretation by raters ranged from 43% to 61%. Inter-rater agreement in detection of tardus parvus waveforms was 76% (136/180 cases, K = 0.44, p < 0.001). Conclusions Detection of tardus parvus waveforms through visual interpretation of spectral Doppler waveform morphology is limited by low accuracy and moderate inter-rater variability. Use of a computer-generated median effective acceleration time cutoff value markedly improves diagnostic accuracy and avoids observer variability.